Continuing Ozanimod Prevented More Relapses in Ulcerative Colitis

(MedPage Today) -- Ulcerative colitis relapses in patients with moderate-to-severe disease were seen as early as 8 weeks among responders who stopped ozanimod (Zeposia) after induction therapy, a post-hoc analysis of the phase III True North study...